Antimicrobial Focus AMR Action Fund is a leading venture fund dedicated to funding antibiotics, antifungals, and other antimicrobials, presenting opportunities to partner on fundraising, co-investments, and strategic partnerships with portfolio companies advancing lifesaving therapies.

Portfolio Growth Recent investments in Telum Therapeutics, F2G, Elion Therapeutics, Utility Therapeutics, Aphage and Venatorx signal a active deal flow and potential for synergistic collaborations or follow-on investment opportunities across antifungal, antibacterial and phage therapy fields.

Policy & Market AMR Action Fund advocates for market reforms and policy solutions, indicating openings for advisory services, policy impact partnerships, and market-access collaborations that could accelerate commercialization of portfolio innovations.

Global Expansion Expansion to Basel and broader European presence suggests a readiness for regional partnerships, co-investments, and deal sourcing in Western Europe, offering opportunities to engage with local biotech ecosystems and potential co-financing.

Tech & Visibility Digital footprint and tech stack indicate modern marketing and investor relations needs; opportunities exist to provide website optimization, content marketing, SEO, and security services to elevate outreach and deal-sourcing activities.